Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
about
Animal models of schizophrenia: a critical reviewAbnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medicationsRIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophreniaPostmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewAssociation between a polymorphism in the pseudoautosomal X-linked gene SYBL1 and bipolar affective disorderReductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist.Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology.Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin.Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depressionAssociation study of SNAP25 and schizophrenia in Irish family and case-control samples.Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia.Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.Neural network models of schizophrenia.Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics.A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophreniaPsychiatric brain banking: three perspectives on current trends and future directions.The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genesIncreased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in SchizophreniaTranscriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia.Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood.Neuroplasticity of neocortical circuits in schizophrenia.Cerebrospinal fluid: identification of diagnostic markers for schizophrenia.Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophreniaSNAP-25a/b Isoform Levels in Human Brain Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex.Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophreniaNeuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia.Synaptic changes in the brain of subjects with schizophrenia.Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder.Gamma oscillation deficits and the onset and early progression of schizophrenia.A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene.A case of paroxysmal kinesigenic dyskinesia which exhibited the phenotype of anxiety disorderCyclic AMP response element-binding protein and depression.Protective role of dark soy sauce against acrylamide-induced neurotoxicity in rats by antioxidative activity.Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects.Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures.Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.
P2860
Q24674909-C7915C1B-9961-43C3-9494-99152C3B8A28Q24682168-CEE478ED-C5DD-456C-98E9-52DAA9655F26Q26269908-D79595E2-12D6-4A16-B4DA-4E367703C59AQ28077391-43DC9D3F-8F9E-4A9A-8BC3-5D989518CC84Q28200777-869F804E-DC4C-43DC-BCB9-E757E1312BEFQ30382547-D7E7B84A-167F-4AF4-86A5-DD4642F13A8DQ30478659-74DEB981-1481-4A17-A9A1-D30DB564DB92Q30610218-05CCFF81-EAB1-4168-A2D2-F34C33A34278Q31162413-92404EEC-E01C-47A8-964E-806517D3D0E1Q33798728-86246BC5-90C0-4DF1-A151-DEE23FD97540Q33809007-C7DCD88A-97CD-4C4F-848C-29B64418E26FQ34179419-CBDC7123-14C3-4942-BE26-3F8EF381189FQ34383654-FF008474-383C-437D-8014-C0BEF2A04803Q34399238-4B342A96-E85F-424C-9754-25BFF4037F33Q34404767-CDD37EA2-C53D-4032-9EDE-D4075300105EQ34593081-A27E1683-BF96-4580-98D8-E1A6224ED0B7Q34660862-CC2D7AFB-89FA-4BA7-B22C-4E2326A72F39Q35017779-92C5B0A5-827C-490A-9391-08CD3DE70435Q35186635-071679B8-8D58-490F-84B0-25531F36ADD7Q35712176-B2037D78-753C-40FD-9161-D137925BED86Q35761611-F4741208-2878-4CFE-BE95-3918774A0FA2Q35918319-19F8B339-68C3-40BE-8AFB-5853DD2B80F1Q36189837-BC4747D7-CA16-4787-BB8E-2C525859F1E3Q36248618-B48D40A3-E30B-45D2-BE31-570B88E09ABCQ36931624-57FCB8B7-1A0C-4306-B4CD-3C75FE79C4A5Q37118995-691C5BE5-D694-4A6F-A343-EAB5844AEE60Q37173934-F609E847-C820-4EE2-B7A3-F232B5A94E29Q37200196-872A0B1B-8BF5-4C8E-82EC-A4C563AF1DEFQ37429365-87D41CEF-0629-49AB-897C-C6E05BB20C20Q37624654-02BBD6BA-8D5B-4EC7-AF8A-883C59B24296Q37850530-20BCC410-D042-471D-B5F9-81AE856F989CQ38299200-147B04CC-E450-4301-8917-22CADC990DD3Q40227588-289A7043-128A-482D-8A75-2742DEB50C3AQ40594390-347454B0-FD95-4E6F-B395-7FB248CFA2A0Q41475738-7515ED25-F10B-4EAB-955E-2090EAB55A93Q43265627-DB2562FA-1C92-45C0-AD8E-EE289EC8418EQ43271999-22A898A5-AC2F-4DED-A39E-0367C7E862D2Q43882777-B0760AA8-4F5B-401E-BBA7-D67B94960AB0Q44279148-CD3514D0-A7A1-40ED-98A9-5F9045BDBC2DQ44507092-4AE97101-5AED-4360-BCF5-1A338A65E4DB
P2860
Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Alterations in synaptic protei ...... al basis for 'hypofrontality'.
@en
Alterations in synaptic protei ...... al basis for 'hypofrontality'.
@nl
type
label
Alterations in synaptic protei ...... al basis for 'hypofrontality'.
@en
Alterations in synaptic protei ...... al basis for 'hypofrontality'.
@nl
prefLabel
Alterations in synaptic protei ...... al basis for 'hypofrontality'.
@en
Alterations in synaptic protei ...... al basis for 'hypofrontality'.
@nl
P2093
P356
P1433
P1476
Alterations in synaptic protei ...... al basis for 'hypofrontality'.
@en
P2093
P2888
P356
10.1038/SJ.MP.4000459
P407
P577
1999-01-01T00:00:00Z
P5875
P6179
1038576800